Rein Therapeutics Inc’s recent filing unveils that its 10% Owner Voss Capital, LP acquired Company’s shares for reported $0.25 million on Oct 28 ’25. In the deal valued at $1.39 per share,178,392 shares were bought. As a result of this transaction, Voss Capital, LP now holds 500,000 shares worth roughly $0.88 million.
Then, Voss Capital, LP bought 97,482 shares, generating $133,544 in total proceeds. Upon buying the shares at $1.37, the 10% Owner now owns 822,258 shares.
Before that, Voss Capital, LP bought 30,176 shares. Rein Therapeutics Inc shares valued at $41,957 were divested by the 10% Owner at a price of $1.39 per share. As a result of the transaction, Voss Capital, LP now holds 729,616 shares, worth roughly $1.28 million.
H.C. Wainwright initiated its Rein Therapeutics Inc [RNTX] rating to a Buy in a research note published on September 22, 2025; the price target was $10. A number of analysts have revised their coverage, including Rodman & Renshaw’s analysts, who began to cover the stock in late January with a ‘”a Buy”‘ rating. William Blair began covering RNTX with “an Outperform” recommendation on July 24, 2017. Jefferies started covering the stock on July 24, 2017. It rated RNTX as “a Buy”.
Price Performance Review of RNTX
On Monday, Rein Therapeutics Inc [NASDAQ:RNTX] saw its stock jump 11.82% to $1.75. Over the last five days, the stock has gained 29.63%. Rein Therapeutics Inc shares have fallen nearly -54.55% since the year began. Nevertheless, the stocks have fallen -23.91% over the past one year. While a 52-week high of $4.16 was reached on 01/29/25, a 52-week low of $1.04 was recorded on 08/04/25.
Levels Of Support And Resistance For RNTX Stock
The 24-hour chart illustrates a support level at 1.4867, which if violated will result in even more drops to 1.2233. On the upside, there is a resistance level at 2.0967. A further resistance level may holdings at 2.4433.
How much short interest is there in Rein Therapeutics Inc?
A steep rise in short interest was recorded in Rein Therapeutics Inc stocks on 2025-10-15, growing by 4755.0 shares to a total of 26079.0 shares. Yahoo Finance data shows the prior-month short interest on 2025-09-15 was 21324.0 shares. There was a rise of 18.23%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on July 24, 2017 when BofA/Merrill began covering the stock and recommended ‘”a Buy”‘ rating along with a $19 price target.
